293 related articles for article (PubMed ID: 18799507)
21. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.
Scheidl SJ; Englisch C; Kovacs G; Reichenberger F; Schulz R; Breithecker A; Ghofrani HA; Seeger W; Olschewski H
Eur Respir J; 2012 Jan; 39(1):119-24. PubMed ID: 21737552
[TBL] [Abstract][Full Text] [Related]
22. Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy.
D'Armini AM; Totaro P; Nicolardi S; Morsolini M; Silvaggio G; Toscano F; Toscano M; Viganò M
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):418-22. PubMed ID: 19934162
[TBL] [Abstract][Full Text] [Related]
23. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
Klok FA; Surie S; Kempf T; Eikenboom J; van Straalen JP; van Kralingen KW; van Dijk AP; Vliegen HW; Bresser P; Wollert KC; Huisman MV
Thromb Res; 2011 Jul; 128(1):21-6. PubMed ID: 21450333
[TBL] [Abstract][Full Text] [Related]
24. [Chronic thromboembolic pulmonary hypertension (CTEPH)].
Lang IM
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S206-8. PubMed ID: 18814098
[TBL] [Abstract][Full Text] [Related]
25. Chronic thromboembolic pulmonary hypertension.
Moraca RJ; Kanwar M
Heart Fail Clin; 2012 Jul; 8(3):475-83. PubMed ID: 22748907
[TBL] [Abstract][Full Text] [Related]
26. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Wong CL; Szydlo R; Gibbs S; Laffan M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and management of chronic thromboembolic pulmonary hypertension.
Klok FA; Huisman MV
Neth J Med; 2010 Sep; 68(9):347-51. PubMed ID: 20876914
[TBL] [Abstract][Full Text] [Related]
28. Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
Escribano-Subias P; Blanco I; López-Meseguer M; Lopez-Guarch CJ; Roman A; Morales P; Castillo-Palma MJ; Segovia J; Gómez-Sanchez MA; Barberà JA;
Eur Respir J; 2012 Sep; 40(3):596-603. PubMed ID: 22362843
[TBL] [Abstract][Full Text] [Related]
29. [Predictive factors of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary thromboembolism].
Mi J; Sun ZH; Zhong MH; Yang YH; Chen T; Xiong GJ; Luo H; Qi XQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):497-501. PubMed ID: 22943645
[TBL] [Abstract][Full Text] [Related]
30. Evaluation and management of chronic pulmonary thromboembolic disease.
Mendoza V; Scharf ML
Hosp Pract (1995); 2011 Aug; 39(3):50-61. PubMed ID: 21881392
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry.
Park SY; Lee SM; Shin JW; Choi BW; Kim H; Lee JS; Lee SD; Park SS; Moon HS; Park YB
Korean J Intern Med; 2016 Mar; 31(2):305-12. PubMed ID: 26689916
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and hemodynamic diagnosis in chronic thromboembolic pulmonary hypertension].
Blanco I; Barberà JA
Arch Bronconeumol; 2009 Jun; 45 Suppl 6():15-20. PubMed ID: 20542196
[TBL] [Abstract][Full Text] [Related]
34. Chronic thromboembolic pulmonary hypertension: role of medical therapy.
Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G
Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
[TBL] [Abstract][Full Text] [Related]
36. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension.
Peacock A; Simonneau G; Rubin L
Proc Am Thorac Soc; 2006 Sep; 3(7):608-14. PubMed ID: 16963542
[TBL] [Abstract][Full Text] [Related]
37. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.
Dorfmüller P; Günther S; Ghigna MR; Thomas de Montpréville V; Boulate D; Paul JF; Jaïs X; Decante B; Simonneau G; Dartevelle P; Humbert M; Fadel E; Mercier O
Eur Respir J; 2014 Nov; 44(5):1275-88. PubMed ID: 25142477
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
39. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
40. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension.
Lankeit M; Dellas C; Panzenböck A; Skoro-Sajer N; Bonderman D; Olschewski M; Schäfer K; Puls M; Konstantinides S; Lang IM
Eur Respir J; 2008 May; 31(5):1024-9. PubMed ID: 18256058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
